Search
Advanced hybrid closed-loop (AHCL) therapy improves glycemia. However, it is not known if there is an improvement in overall outcomes with AHCL for youth with type 1 diabetes (T1D) at high risk of diabetes-related complications. The study aimed to capture the experiences of youth with suboptimal glycemic control when commencing AHCL therapy in a clinical trial setting.
Continuous glucose monitoring (CGM) can detect early dysglycemia in older children and adults with presymptomatic type 1 diabetes and predict risk of progression to clinical onset. However, CGM data for very young children at greatest risk of disease progression are lacking.
A type 1 diabetes (T1D) transition clinic in Sydney, Australia, provides age specific care for young adults (aged 16-25 years) and for adults (aged 21 years and above), and has reported improved clinical outcomes post transition to adult care over a 21-year period. This study investigated the contribution of digital technology to long-term resilient capacity of the clinic.
Jake's diabetes journey Age when diagnosed; two years-old, almost three.
Last month, our Centre's co-Director Liz Davis, attended the National Association of Diabetes Centre's (NADC) Symposium in Sydney.
Patients, families and our centre staff members took part in JDRF's One Walk last October to raise funds for type 1 diabetes research.
You may have heard we're moving to our new home at Perth Children's Hospital later this year, sadly this means we've had to cancel our camps.
We can work together during normal appointments to make sure prescriptions are written, so please ask us if you need a prescription during clinic time.
We are looking to create exciting new online resources for our families to utilise, which will include how-to videos, as well as patient perspective interviews.